FRANKFURT (Reuters) - Bayer's experimental riociguat pill showed promise against a life-threatening form of high blood pressure in the lungs, a potential challenge to existing treatments from Actelion and Gilead. In a late-stage trial, the drug helped people suffering from pulmonary arterial hypertension (PAH), a progressively worsening condition that can overburden the heart, to better tolerate physical exercise and improve heart function, Bayer said on Monday. The results will be presented at this week's annual meeting of the American College of Chest Physicians (ACCP) in Atlanta. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment